Clinical Challenge
Tumor therapy with high-intensity focused ultrasound (HIFU) is a promising, noninvasive alternative to surgical intervention. Although this therapy is used clinically to treat prostate cancer, uterine fibroids and bone metastases, there are still challenges to overcome, for example a reliable treatment planning as well as the prediction of the outcome. The treatment of abdominal diseases such as liver or kidney tumors is even more challenging due to respiratory motion and ribcage shielding, which prevent the application of HIFU therapy to abdominal tumors in daily clinical practice.